Affinia Therapeutics IPO

Affinia Therapeutics’ purpose is to develop gene therapies that can have a transformative impact on people affected by devastating rare and non-rare diseases and methodically engineers novel AAV vectors and regulatory elements to make gene therapies with potentially improved tissue tropism, cell specificity, safety, and yields.

Register for Details

For more details on financing and valuation for Affinia Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Affinia Therapeutics's ticker symbol?

Affinia Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Affinia Therapeutics's stock price?

The stock price for Affinia Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Affinia Therapeutics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
5/3/2021 Series B $365.7MM $XXX.XX $XXX.XX
3/31/2020 Series A $116.71MM $XXX.XX $XXX.XX
11/5/2019 Series A-1 $42.61MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Affinia Therapeutics

What is Affinia Therapeutics funding to date?

Affinia Therapeutics has raised $179.09MM with the following series:
$42.61MM for Series A-1, $116.71MM for Series A, $365.7MM for Series B

When was Affinia Therapeutics founded?

Affinia Therapeutics was founded in 2019.

Can you invest in Affinia Therapeutics?

Affinia Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Affinia Therapeutics share pre-IPO?

If you own Affinia Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Is Affinia Therapeutics a publicly traded company?

Affinia Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Affinia Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$327.39MM
Sector